Trials / Conditions / H7N9 Influenza
H7N9 Influenza
5 registered clinical trials studyying H7N9 Influenza.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Influenza A (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP) NCT06417853 | Vaxxas Pty Ltd | Phase 1 |
| Completed | A Study of An Adjuvanted Inactivated H7N9 Influenza Vaccine NCT03755427 | Shanghai Institute Of Biological Products | Phase 2 |
| Completed | Safety and Immunogencity of H7N9 Influenza Antigen With 2 Adjuvant Formulations in Healthy Adults in Brazil NCT03330899 | Butantan Institute | Phase 1 |
| Completed | A Clinical Trail Of An Adjuvanted Inactivated H7N9 Influenza Vaccine NCT03369808 | Shanghai Institute Of Biological Products | Phase 1 / Phase 2 |
| Completed | Dose-finding Study of Four Dosage Levels of an H7N9 Influenza Vaccine in Adults Between Ages of 18 Years and 6 NCT01928472 | Novartis Vaccines | Phase 1 |